This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

A Pair of Hot Dividend-Paying Stocks to Buy Now

Stocks in this article: PFE VZ LVS MRK S AAPL WMT T

NEW YORK ( TheStreet) -- Owning stocks that pay super-sized dividends when the market is trending higher is a powerful way to get free portfolio insurance in case the market takes a breather.

Regardless of your stocks are gaining value, you get paid to own them. Receive enough dividends and your stocks are essentially free cash-disbursing ATMs once a quarter.

With that in mind, if you can find stocks that pay massive dividends and are bullish based on their chart pattern, you have a recipe to stack the odds in your favor. We don't know what will happen next, albeit in the same way the Las Vegas Sands (LVS) prospers we do our best to gain an edge and let the law of averages work in our favor.

After watching the Green Bay Packers put 38 points on the board and a win Sunday, I researched and found stocks that are not only notable dividend payers, but promising buys right now. Here are what I found.

PFE Dividend Yield (TTM) Chart PFE Dividend Yield (TTM) data by YCharts

Pfizer (PFE)

Background: Pfizer, a biopharmaceutical company, engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide.

Price To Book: 2.4

Earnings Payout Percentage: 25%

Shareholders receive 96 cents annually in dividend payments. That places the yield about 3.3%; in relation to a shrinking payout percentage, it is one of the best yields you can find on Wall Street.

Pfizer has plenty of competitors in the space. One that particularly stands out is Merck (MRK) right now. I would wait for a buying dip in price to enter, for example, under $48. Also, while Merck pays a slightly higher dividend yield, the payout percentage is expected to top 50%, even with expected earnings to grow to $3.68.

Pfizer and Merck are widely held, and there is a compelling reason for it -- they both deliver to shareholders. Pfizer is my first choice, but Merck deserves an honorable mention, especially for investors that already own Pfizer and want diversification.

Pfizer's shares are up about 14% from a year ago, and the average analyst price target is $31.59. I don't put a tremendous amount of weight on analysts' price targets but it is one more factor to consider.

There's almost zero desire by short-sellers to move against this stock. Short interest hardly moves the needle with only 0.9% of the float. Never underestimate how informative short interest is. If the smartest guys in the room aren't excited about placing a bet the stock is overpriced, it probably isn't.

PFE Payout Ratio TTM Chart PFE Payout Ratio TTM data by YCharts

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs